Cancer diagnosis rates are rising faster in sub-Saharan Africa than in any other region globally, presenting significant challenges to healthcare systems already strained by limited resources. The World Health Organization projects that cancer cases in the region will more than double by 2050, with the Eastern Mediterranean region experiencing the second-highest rate of increase. Nigeria exemplifies these pressures, where multiple factors contribute to the surge in cases, including an aging population, increased tobacco and alcohol consumption, and urban sedentary lifestyles.
Nigeria’s healthcare infrastructure struggles to meet current demand, let alone prepare for anticipated increases. The country has approximately 80 oncologists serving a population of 242 million people, compared to roughly 27,500 oncologists in the United States for a population of 340 million. Additionally, Nigeria operates only 15 radiation therapy centers despite radiation being required by more than half of cancer patients globally. Many trained Nigerian physicians relocate abroad for better opportunities, further depleting local expertise. Radiation oncologist Dr. Basira Hanafi Lawal reports that she frequently sees crowds of patients, some traveling up to eight hours for treatment, with roughly 70% of her patients presenting at stage 3 or 4 cancer—when tumors have advanced significantly.
Financial barriers compound the clinical challenges. In Nigeria, patients cover more than 80% of cancer care costs out-of-pocket, as most health insurance plans do not include comprehensive cancer coverage. Families frequently resort to bank loans, workplace loans, and crowdfunding to afford treatment. This financial burden discourages many from seeking care and forces some to abandon treatment entirely. Five-year survival rates reflect these disparities: only 28% of Nigerian women diagnosed with breast cancer survive five years, compared to the global median of 78%.
Survivors face additional obstacles including social stigma, community rejection, and isolation. The Nigerian government has responded by establishing the Nigerian Cancer Health Fund in 2020 to assist low-income patients and setting a goal to reduce cancer cases by 30% by 2030. Prevention efforts include introducing the human papillomavirus vaccine, which Kenya added to routine immunization in 2019 and Nigeria adopted in 2023 to prevent cervical cancer. International organizations are collaborating with governments to expand infrastructure and improve access to treatment through awareness campaigns and screening programs.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI